Xenoglim Mv2 Tablet is a pharmaceutical product that combines Glimepiride, Metformin, and Voglibose for effective management of diabetes.

SKU: 70639 Categories: ,


Xenoglim Mv2 Tablet is a pharmaceutical product composed of three active ingredients – Glimepiride, Metformin, and Voglibose. This medicine is mainly used to manage and control blood sugar levels in individuals with type 2 diabetes mellitus.

Glimepiride belongs to a class of medications called sulfonylureas, which work by stimulating the pancreas to produce more insulin and increasing the body’s sensitivity to insulin. Metformin is a biguanide that helps reduce the amount of glucose produced by the liver and improves insulin sensitivity in muscle and fat tissues. Voglibose is an alpha-glucosidase inhibitor that slows down the digestion and absorption of carbohydrates in the intestine, thereby preventing sudden rises in blood sugar levels after meals.

Xenoglim Mv2 Tablet is beneficial in treating type 2 diabetes by effectively lowering blood sugar levels. It is used as an adjunct therapy alongside a healthy diet and regular exercise to maintain glycemic control. This combination medication is suitable for patients whose blood sugar cannot be controlled by diet and exercise alone or for individuals already using one or two of the components but requiring additional glycemic control.

It is important to note that this medication is not recommended for individuals with type 1 diabetes or diabetic ketoacidosis. It is also contraindicated in patients with severe kidney or liver problems, severe infections, and certain gastrointestinal disorders.

In conclusion, Xenoglim Mv2 Tablet is a combination medication containing Glimepiride, Metformin, and Voglibose. It is prescribed primarily for individuals with type 2 diabetes to help manage blood sugar levels. By targeting different mechanisms, this medication offers effective glycemic control and contributes to the overall treatment plan for individuals with type 2 diabetes. However, it is crucial to consult with a healthcare professional before starting or altering any diabetes management medication.

Additional information

Weight 25.0 g
Marketed by


Dosage form




Therapeutic use